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Summary
Background.— Arterial hypertension is managed mainly by general practitioners. The blood
pressure level of most patients treated in a general practice setting is greater than or equal to
140/90mmHg.
Aims.— To understand why a blood pressure level greater than or equal to 140/90mmHg does
not lead to a change of treatment.
Methods.— Over a 2-week period, 479 hypertensive patients were included in a cross-sectional
study by 27 general practitioners. Consultation data were collected, as were reasons why
patients with a blood pressure level greater than or equal to 140/90mmHg did not have their
treatment changed.
Results.— Blood pressure level was greater than or equal to 140/90mmHg in 58% of patients;
treatment was changed in 15% of these individuals. The lack of change in treatment was justiﬁed
by the physicians as follows: the blood pressure measurements were not considered to be
representative (about 30% of cases); the therapeutic result was considered to be satisfactory in
the circumstances (about 30% of cases); change was not appropriate given the patient’s speciﬁc
context (the remaining third of cases). The proportion of uncontrolled hypertensive patients
whose treatment remained the same was signiﬁcantly higher among patients with a disease
that affected their lifestyle or threatened their life expectancy.
∗ Corresponding author. Fax: +33 5 62 88 90 84.
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générale ne sont pas le seul fait d’une mauvaise application des référentiels. La difﬁculté
d’interprétation des chiffres de PA, des recommandations changeantes et souvent peu claires
ainsi que la prise en considération du contexte clinique spéciﬁque de leurs patients sont les
trois facteurs majoritairement invoqués par les praticiens.
© 2009 Elsevier Masson SAS. Tous droits réservés.
A
A
B
C
G
R
B
A
r
a
m
e
s
I
h
t
‘
c
o
t
r
t
s
a
t
o
a
t
c
t
i
r
a
I
g
o
w
c
a
l
m
w
Sbbreviations
HT arterial hypertension
P blood pressure
I conﬁdence interval
P general practitioner
IAT reasons for not intensifying antihypertensive treat-
ment
ackground
HT is a major public health problem and an important
isk factor for cerebrovascular accident, coronary disease
nd heart and kidney failure. Effective treatments exist and
anagement guidelines are disseminated regularly by sci-
ntiﬁc societies [1]. Nevertheless, various epidemiological
tudies have shown that BP control is inadequate [2—5].
t is important to understand why the BP level of 70% of
ypertensive patients treated in a general practice set-
ing is greater than or equal to 140/90mmHg—–that is,
‘uncontrolled’’ by treatment. This observation is not spe-
iﬁc to AHT. In the ﬁeld of lipid-lowering therapies, 74%
f patients treated in France did not attain the therapeu-
ic objective [6]. AHT is managed mainly by GPs, who are
esponsible for 94% of the consultations with diagnosed and
reated patients. A 1994 survey on AHT in general practice
p
d
w
l
ahowed that 24% of treated hypertensive patients had not
ttained the 140/90mmHg cut-off point [3]. In 1999, with
he same methodology, this proportion did not exceed 32%
f treated hypertensive patients. It would therefore be valu-
ble to seek to understand the disparity that exists between
he guidelines of scientiﬁc societies, agencies and expert
onsensuses on the one hand, and the practices of GPs on
he other [7,8]. Lack of familiarity and scepticism regard-
ng reviews of this decision threshold over time and with
egard to the various scientiﬁc societies have been stressed,
nd also the disparity between practices and guidelines.
n addition, it is important to take the speciﬁc context of
eneral practice into account. For the GP, it is a matter
f obtaining a long-term result, of maintaining compliance
ith the antihypertensive treatment, while dealing or even
ompeting with other health goals, concomitant diseases
nd, more generally, with speciﬁc events in a patient’s
ife.
A change of treatment, in order to lower BP by a few
mHg, means exposure to the risk of new adverse effects,
hich are likely to alter and disturb treatment compliance.
imilarly, BP control is not necessarily the top priority for a
atient with another disease, or one who is going through aR. Nicodème et al.
Conclusion.— The disappointing therapeutic results observed in the management of arterial
hypertension do not arise only from poor application of guidelines by general practitioners.
Reluctance to rely on blood pressure measurements, a perception that guidelines are revised
frequently and are not always clear, and consideration of the general practitioner’s activity in
the patient’s speciﬁc context are the main factors involved.
© 2009 Elsevier Masson SAS. All rights reserved.
Résumé
Contexte.— La majorité des hypertendus sont suivis par leurs médecins généralistes et la
pression artérielle (PA) de ces patients est souvent supérieure aux recommandations.
Objectifs.— L’objectif de cette étude est de comprendre pourquoi des PA supérieures à
90/140mmHg ne conduisent pas les praticiens à modiﬁer leurs traitements.
Méthodes.— Pendant deux semaines, 479 patients hypertendus traités ont été inclus par 27
omnipraticiens dans une étude transversale. Les données de consultation ont été collectées
ainsi que les raisons de non-modiﬁcation thérapeutique lorsque les PA des patients dépassaient
90/140mmHg.
Résultats.— Les PA étaient supérieures aux recommandations pour 58 % des patients et la
thérapeutique n’a été changée que pour 15 % d’entre eux. Le statu quo thérapeutique était
justiﬁé par les médecins généralistes par une non-représentativité des mesures dans 30 % des
cas, par des mesures satisfaisantes compte tenu des circonstances dans 30 % des cas et pour le
dernier tiers par le contexte clinique spéciﬁque de leurs patients. Parmi les patients dont le
traitement est resté inchangé, ceux qui étaient affectés par une pathologie altérant leur mode
de vie ou leur pronostique vital étaient signiﬁcativement plus nombreux que les autres.
Conclusion.— Les mauvais résultats tensionnels des hypertendus traités et suivis en médecineifﬁcult period in their personal life. The aim of this study
as to understand why, despite recognition of the prob-
em, a BP level of at least 140/90mmHg does not lead to
change of treatment in general medical consultations. In
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other words, we wished to ﬁnd out what lies behind this
so-called ‘‘clinical inertia’’ [9].
Methods
Population
In this cross-sectional study, all 52 physicians in the Midi-
Pyrénées region of southwestern France who had a resident
in training in 2003 were invited to participate. Physicians
who declined to participate or who did not have a resident in
training were excluded. Each volunteer physician included
consecutively, without selection, all hypertensive patients
seen in consultation at the surgery, aged 18 years and over
and currently receiving pharmacological treatment. Patients
with AHT not treated pharmacologically, with AHT diagnosed
during the week of the study, who declined to participate or
who were not ﬂuent in French were excluded.
Sample size
A reason for noninitiation of treatment change with a 20%
frequency should be evaluated with a 95% CI. In a previous
survey carried out by the same investigators, 16 physicians
recruited 260 hypertensive patients in 1 week, including 240
treated hypertensive patients, of whom 160 had a BP level
greater than or equal to 140/90mmHg, which represented
about 15 treated hypertensive patients (10 of whom had
high BP levels) per physician per week. On this basis, the
52 supervising GPs in our survey were estimated to be able
to include 500 treated hypertensive patients with high BP
levels over a period of 2 weeks.
Data collection
The resident gave each patient who met the inclusion crite-
ria an information sheet and explained the purpose of the
study. Patients who agreed to participate then gave oral
informed consent. Patient history and details concerning the
consultation, BP level and treatment were collected by the
resident. At the end of the consultation with the GP, they
were asked for the reasons why they had not changed the
treatment of a patient whose BP level was greater than or
equal to 140/90mmHg (deﬁned as hypertension not con-
trolled by treatment). The BP level used was the mean of
the two measurements taken by the GP. Before the start of
the survey, the physicians who volunteered to take part in
the study and their residents received training in completion
of the questionnaires. A self-administered questionnaire on
declared compliance and dietary habits was distributed in
the waiting room to patients who had given their consent.
All records in which BP measurements were missing were
excluded (43 of 522 records, or 8.2%).Statistical analysis
All data were analysed using STATA 9® software. Qualitative
data were compared with the Chi-square test and quantita-
tive variables with Student’s test.
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n479
esults
opulation description
hysicians
ifty-two physicians were invited to take part in the study
nd 27 agreed (age range: 38—65 years; mean age: 52; 89%
en). The mean number of patients included per physician
as 19 (range: 12—30).
atients
total of 479 completed questionnaires were available for
nalysis. The proportion of men was 47% and the mean
ge± 95% CI was 68.4± 2.6 years. Our sample was not
ntirely representative of the population of the region, as
he population of the Haute-Garonne administrative area
as overrepresented. In 70% of cases, the consultation
elated to BP control; the remaining 30% of cases were
elated equally to acute diseases and chronic diseases. The
easured and calculated arterial BP level was greater than
r equal to 140/90mmHg in 57.4% of cases. This same pro-
ortion of patients was estimated by the physicians as being
bout 40%. Among the patients included, 22% had a dis-
ase that affected their lifestyle and 10% had a disease that
hreatened their life expectancy. The principal diseases that
ffected lifestyle were rheumatological (35%), neuropsychi-
tric (35%) and cancerous (11%). The diseases threatening
ife expectancy were cancerous in 38% of cases.
omparison of controlled and uncontrolled hyperten-
ive patients
ystolic and diastolic BP levels were 128.4± 1.1 and
5.8± 1.0mmHg, respectively, in controlled hypertensive
atients and 150.9± 1.7 and 84.8± 1.3mmHg in uncon-
rolled hypertensive patients (both p < 0.001). Time since
iagnosis of AHT did not differ between groups. For uncon-
rolled hypertensive patients, systolic pressure levels were
bove 140mmHg in 75% of cases, above 150mmHg in 50%
f cases and 155mmHg in 25% of cases. Diastolic BP lev-
ls were above 90mmHg in only 25% of cases. Age and
ex did not differ between the two groups. Farmers, arti-
ans and workers were more likely to have uncontrolled BP
han executive staff, intermediate professions or employees
Table 1). Patients with a disease affecting their lifestyle
r threatening their life expectancy were more likely to
ave poorly controlled BP than those without such diseases
p = 0.04).
The prevalence of risk factors (smoking, dyslipidaemia,
iabetes, family history of cardiovascular disease) did not
iffer between the controlled and uncontrolled groups.
o differences were observed in the involvement of tar-
et organs: left ventricular hypertrophy, proteinuria, serum
reatinine, heart failure, coronary disease or peripheral vas-
ular disease.
reatment change in uncontrolled hypertensive
atients
n the group of 275 patients with poorly controlled BP, only 38
15%) had their treatment changed (out of a total of 261, as
ata were incomplete for 14 patients). Among uncontrolled
atients, the types of treatments, both antihypertensive and
on-antihypertensive, as well as the number of treatments
480 R. Nicodème et al.
Table 1 Population and AHT control.
Number of patients (%) p
Controlled hypertensive
patients (N = 204)
Uncontrolled hypertensive
patients (N = 275)
Profession (Inseea classiﬁcation)
Farmers 2 (1) 11 (4.3) < 0.05
Artisans, shopkeepers, business owners 7 (3.6) 17 (6.7)
Executives, higher intellectual professions 10 (5.2) 7 (2.8)
Intermediate professions 3 (1.6) 2 (0.8)
Employees 16 (8.3) 11 (4.3)
Workers 3 (1.6) 15 (5.9)
Retired 140 (72.2) 175 (68.9)
No professional activity 13 (6.7) 16 (6.3)
Missing values 10 21
Sex
Men 97 (47.8) 127 (46.7) ns
Women 106 (52.2) 145 (53.3)
Missing values 1 3
Disease affecting lifestyle or life expectancy
Yes 42 (20.8) 80 (29.2) < 0.05
Missing values 2 1
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y prescription were not different whether the treatment
as changed or not. The antihypertensive treatment modi-
cations were addition of a drug (37% of cases), change of
ne of the antihypertensive drugs (18% of cases), increase
f posology (26% of cases), suppression of an antihyperten-
ive drug without substitution of the drug to reassess BP
evel and cardiovascular risk (10% of cases) and addition of
on-antihypertensive drugs (9% of cases).easons given by the physicians
oninitiation of treatment change was justiﬁed by the
hysicians as follows: they did not consider the BP mea-
urements to be representative (about 30% of cases); they
c
T
w
c
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Table 2 Reasons given by physicians for not changing treatmen
Interpretation Reason given by physici
BP reading Today’s BP reading does
Nonadherence to guidelines BP level is satisfactory
Diastolic BP level is sati
Other reasons related speciﬁcally
to context of consultation
BP is not the reason for
BP level will improve w
BP level will improve w
Patient reluctant to cha
BP level is borderline
BP is not the main prob
Treatment change unlik
Fear of adverse effects
Earlier attempts at trea
Awaiting laboratory res
Omission (difﬁcult consonsidered the therapeutic result to be satisfactory in the
ircumstances or the diastolic BP to be adequate without
onsidering systolic BP (about 30% of cases); they gave other
easons in the remaining third of cases (Table 2).
ircumstances of treatment change
reatment change did not differ by sex or age, nor by history
f cardiovascular disorders such as coronary artery disease,
ongestive heart failure or arteritis of the lower limbs.
reatment was more often changed when the consultation
as related to hypertension (16.7%) than when the patient
onsulted for another reason (6.4%; p < 0.05). The proportion
f treatment change in uncontrolled hypertensive patients
t in uncontrolled hypertensive patients (≥ 140/90mmHg).
an for not changing treatment No. of patients (%)
not represent the usual BP level 50 (30.1)
in the circumstances 45 (27.1)
sfactory 4 (2.4)
consultation 19 (11.5)
ith present treatment 10 (6)
ith compliance 10 (6)
nge treatment 8 (4.8)
7 (4.2)
lem of this consultation 4 (2.4)
ely to improve BP level 3 (1.8)
if treatment intensiﬁed or changed 2 (1.2)
tment change unsuccessful 2 (1.2)
ult or cardiologist’s opinion 2 (1.2)
ultation) 0 (0)
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increased with the increasing grade of AHT: 10.5%, 24.5%
and 29.5%, respectively, for grades I, II and III (p < 0.05).
The proportion of uncontrolled hypertensive patients
whose treatment remained the same was signiﬁcantly higher
among patients who had a disease that affected their
lifestyle or one that threatened their life expectancy.
Patient-declared compliance
Inadequate compliance declared by the patient in the self-
reported questionnaire was more frequent in uncontrolled
(26.5%) than in controlled hypertensive patients (17.1%)
(p < 0.05). However, the proportion of treatments changed
by the GP in uncontrolled hypertensive patients did not dif-
fer according to patient-declared compliance.
Discussion
Three types of factor came to light in this study of why
GPs did not change the antihypertensive treatment of their
patients who had high BP levels according to accepted guide-
lines. The ﬁrst concerned consideration by the GP of the
patient’s overall health status. We observed in this survey
that the physician was less likely to change the treatment of
those patients who had a disease that affected their lifestyle
or threatened their life expectancy. Similarly, the physicians
stated that considerations of long-term compliance, fear of
adverse effects, the expectation of achieving results in the
long term or consultation for a problem other than AHT were
major reasons for not initiating treatment change.
The second reason was related to BP measurement difﬁ-
culties and physicians’ reluctance to change treatments on
the basis of a variable in which they did not have conﬁdence.
Indeed, in a third of cases in which they did not change treat-
ment, the physicians declared that the BP measured at the
time of consultation was not representative of the usual BP
level. If 30% of the patients stated that they owned a BP
self-measurement device, no information was recorded in
our study to detail whether it was used in the framework of
a follow-up by the GP or even if it was used at all.
Thirdly, and lastly, our survey showed a partial lack of
adherence to ofﬁcial guidelines. This related essentially to
the level of systolic pressure that is considered to be nor-
mal or that should be attained with treatment. In about one
third of cases, physicians considered that BP was satisfac-
tory in the context of their patients’ lives, based on diastolic
pressure alone.
Certain limitations of our study should be underlined.
The participation rate of the GPs was only 52%, which is
hardly surprising in a population for whom research is not
a major concern. This was reﬂected in the 8% of patient
records that were excluded because they did not contain
the BP readings. This selected physician population is proba-
bly not very representative of French GPs. Nevertheless, the
results observed among their practice differ little from those
observed in previous works. As in earlier studies, BP control
was a problem affecting fewer than half of the patients,
and control was less satisfactory in certain social categories
such as workers, whereas it was maximum in higher socioe-
conomic categories [10].
The range of reasons why the GP did not change treat-
ment despite the readings justifying such a change may be
discussed under three headings:
t
m
c
a481
the need for long-term negotiation with a patient whose
overall status is taken into account;
the lack of conﬁdence in BP measurements;
a somewhat distant attitude to accepted guidelines.
The same observations were made in the RIAT study of
621 hypertensive patients, in which several reasons were
dentiﬁed for not intensifying antihypertensive treatment at
he end of the consultation despite unsatisfactory measure-
ents. Of the two principal reasons, one concerned the time
ince the initiation of the current treatment being too short
o be able to assess treatment efﬁcacy. The other related
o BP measurement, with adequate improvement after the
tart of treatment or satisfactory self-recordings. But this
tudy provided no information on the attitude of the physi-
ians toward guidelines [11].
In the group of patients with poorly controlled BP (57% of
atients), only 15% were prescribed a different treatment.
either age nor sex was related to treatment change. But
he GPs appeared to be attentive to their patients’ histories
nd lifestyles when they changed or intensiﬁed hypertensive
reatment. During consultations for reasons other than BP
onitoring (an acute or other disease), treatment changes
ere fewer than during consultations motivated by hyper-
ension. The study reﬂects increased tolerance of high BP
easurements in patients with a disease that affects their
ifestyle or their life expectancy.
The notion of context encompasses the whole nature of
he consultation, whether it is for acute disease or mon-
toring of chronic diseases, or is related to events in the
atient’s life. Context is an element likely to modulate the
igour with which the short-term or long-term treatment
f hypertension is addressed. The GP must respond to the
atient’s needs and manage the various problems in order
f importance. During consultations for an acute problem,
oorly-controlled BP may be considered to be a secondary
oncern, as in patients who have a disease that affects their
ifestyle or their life expectancy. Furthermore, a long-term
elationship is a characteristic of general practice. So for
early 40% of cases in which ‘‘BP level will improve with
resent treatment’’, the high BP was recorded but was not
cted on while ‘‘awaiting laboratory result or cardiologist’s
pinion’’.
Lastly, BP was not necessarily the main priority of the
resent consultation, but could be dealt with at a later date.
he RIAT study [11] had already emphasized that one of
he reasons for nonmodiﬁcation of treatment was that the
urrent treatment had been initiated too recently for its
fﬁcacy to be assessed. This attitude is similar to another
eason mentioned—–the assumption that BP would improve
ith compliance.
More surprising was the ﬁnding that the proportion of
atients with a history of risk factors for cardiovascular
iseases, coronary insufﬁciency or congestive heart failure
as not higher among patients with well-controlled BP than
mong those with poorly-controlled BP, as physicians might
e expected to follow these at-risk patients more atten-
ively.
Over the years, successive deﬁnitions of AHT and treat-
ent guidelines have been published. Faced with these
hanges, physicians are aware of ofﬁcial guidelines [5] but
ppear to follow their own. They consider, for example, that
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he ‘‘BP level is satisfactory in the circumstances’’, or they
eglect systolic BP in order to concentrate on diastolic BP.
Guidelines succeed guidelines and cut-off points fol-
ow cut-off points, whereas the link between AHT and risk
emains constant. Guidelines are complex to read and do not
ake account of the balance to be sought between desirable
linical aims and the patient’s wishes. Lastly, to succeed in
owering the last few mmHg and attaining the target means
dding a new treatment with risks that are not less than
hose of the ﬁrst treatment [12]. In another chronic disease,
iabetes, GPs are also involved closely with guidelines.
Physicians know the guidelines, but stress that they have
o be adjusted to the individual nature of each patient. This
ecessity does not account entirely for the departure from
he guidelines, however. Lack of adherence to recommen-
ations was underlined with regard to bovine spongiform
ncephalopathy, by the fact that only 44% of GPs who
dvised their patients to change their dietary habits did so
hemselves in their own homes [13]. In our present study,
reated, uncontrolled, hypertensive patients had mainly
ure grade 1 systolic hypertension, as was observed in other
tudies of practices relating to hypertensive patients in pri-
ary prevention [14].
This ﬁnding is not conﬁned to the general practice set-
ing; a survey in secondary prevention in coronary patients
ith hypertension showed that 32.5—38.8% achieved BP
oals and that 50% of uncontrolled hypertensive patients
ad mild hypertension [2]. Given the age range of patients
ecruited in this study, the difﬁculty of controlling systolic BP
s not surprising. But the predictive value of systolic BP over
he age of 55 years should be stressed. The conciliatory atti-
ude of GPs to systolic BP has already been underlined [15].
n the general practice setting, increased awareness of the
mportance of systolic BP management should be one of the
ims of continuing medical education. A prerequisite is to
estore the conﬁdence of practitioners in BP measurement,
s lack of conﬁdence accounted for 30% of the explanations
or maintenance of a treatment which was a priori ineffec-
ive.
These ﬁndings are in line with the fact that the ‘‘white
oat effect’’ accounts for a nonnegligible proportion of
esistance to treatment: 20% of uncontrolled AHT may be
elated to this effect [16], particularly in elderly patients
17]. This reluctance was conﬁrmed by the study of God-
in et al. [18], which showed that only 69% of patients
ound to have uncontrolled hypertension in the family physi-
ian’s ofﬁce did in fact have uncontrolled hypertension on
4-hour ambulatory monitoring. On the other hand, GPs do
ave conﬁdence in BP self-measurement. Moreover, self-
easurement has been found to have better prognostic
ccuracy than ofﬁce-measurement of treated AHT [19]. The
005 guidelines issued by the French Haute Autorité de santé
ave extended the indications for self-measurement. A pri-
rity for improving AHT management could be to clarify the
nterpretation of ofﬁce BP measurements.
Whether these results can be valid in other health
ontexts needs to be conﬁrmed. However, poor BP con-
rol, so-called ‘‘clinical inertia’’ and lack of conﬁdence in
P measurement have been reported in various countries
5,11].
Our ﬁndings suggest that the disappointing therapeutic
esults observed in AHT management in the general popula-R. Nicodème et al.
ion and in general practice, and clinical inertia, do not arise
nly from poor application of guidelines by GPs. Three prin-
ipal factors help us to understand this situation: reluctance
o rely on BP measurements which show marked variabil-
ty; a perception of guidelines being revised frequently,
iable to change and not always clear; and consideration
f the GP’s activity in the patient’s speciﬁc context. Eval-
ation of various interventions to improve AHT control in
rimary care have shown that there are no obvious solutions
20], although ambulatory measurement, use of feedback
o inform the physician of the true state of control in his or
er population of treated patients, or of reminder systems
s suggested by Pickering [5], open interesting perspectives
or the future.
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